Pfizer, Inc.

Form 483 issued November 21, 2016 · Rochester, Michigan

Inspection
Nov 14 – Nov 21, 2016
Observations
2
Pages
4
FEI number
1876582

In short: On November 21, 2016, FDA issued a Form 483 with 2 observations to Pfizer, Inc. in Rochester, Michigan (FEI 1876582) after an inspection that ran Nov 14 – Nov 21, 2016. The investigators were Aurora-Miha Trifanov, Emilie Kahn and Emily J. Orban. Most observations concern production and materials; the most-cited regulation is 21 CFR 211.111 (time limitations on production).

At a glance

Production and materials account for 2 of 2 observations.

Production1
Materials1

Most cited: 21 CFR 211.111 (1×) · 211.80(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Time limits are not established when appropriate for the completion of each production phase to assure…

  2. 02

    Written procedures are not followed for the receipt, identification, storage, handling and approval of components…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pfizer, Inc.?

FDA listed 2 observations on this Form 483, mostly about production and materials. The most-cited regulation is 21 CFR 211.111 (time limitations on production). The opening words of each observation are shown on this page.

Who inspected Pfizer, Inc.?

Aurora-Miha Trifanov, Emilie Kahn and Emily J. Orban are named on this Form 483, for the inspection of Nov 14 – Nov 21, 2016. Each investigator has a profile showing what they cite most.

When was Pfizer, Inc. inspected by FDA?

The inspection ran Nov 14 – Nov 21, 2016, and the Form 483 is dated November 21, 2016.

How do I get the full Form 483 for Pfizer, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free